Humana stock price target raised to $336 from $300 at CFRA

Humana stock price target raised to $336 from $300 at CFRA

Humana beats earnings expectations, raises outlook

Humana Inc. reported second-quarter net income of $19 million, or $1.39 a share, compared with $1.04 billion, or $4.46 a share, in the same period a year ago. Excluding non-recurring items, such as a $790 million loss on the sale of its KMG America Corp. subsidiary, adjusted earnings per share rose to $3.96 from $3.49, beating the FactSet consensus of $3.77. Total revenue increased 5.4% to $14.26 billion, above the FactSet consensus of $14.11 billion, as premiums grew 3.9% to $13.71 billion to beat expectations of $13.48 billion. The health care company raised its 2018 adjusted EPS guidance to $14.15 from a previous range of $13.70 to $14.10. The revenue outlook was nudged up to $55.9 billion to $56.5 billion from $55.8 billion to $56.4 billion. The stock, which was still inactive in premarket trade, has run up 27% year to date, while the S&P 500 has gained 5.3%.

Read on Market Watch


Author: HEDGE

Hedge Accordingly was founded ahead of the global financial crisis in January of 2008, with the goal of providing our readers our unique take on The Latest News on Wall Street, Stocks, #Politics and Business news. Hedge Accordingly produces both original, and aggregated #Wallst news content from top publishers around the world. We curate aggregated content covering the latest news on politics, stocks, wall street, and the tech industry. We also provide free stock charting, quotes and a bitcoin, forex and currency exchange. Learn More About